Picture of Advicenne SA logo

ALDVI Advicenne SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Advicenne FY Operating Loss Widens To 6.0 Million Euros

April 10 (Reuters) - ADVICENNE SA  ADVIC.PA :
    * FY REVENUE EUR 0.6 MILLION VERSUS EUR 0.3 MILLION YEAR AGO
    * FY OPERATING LOSS EUR 6.0 MILLION VERSUS LOSS EUR 3.2
MILLION
YEAR AGO
    * FY NET LOSS EUR 6.0 MILLION VERSUS LOSS EUR 3.6 MILLION
YEAR AGO
    * PLANS TO LAUNCH TWO PIVOTAL STUDIES WITH ADV7103 IN 2018
    * ADV7103: PLANS TO LAUNCH IN H2 PHASE II/III PIVOTAL
CLINICAL
TRIAL IN US IN DRTA PATIENTS
    * ADV7103: PLANS TO LAUNCH IN H1 PHASE II/III PIVOTAL
CLINICAL
TRIAL IN EUROPE IN CYSTINURIA PATIENTS
    * CASH AND CASH EQUIVALENTS AT END-DEC. EUR 36.2 MILLION

Source text : https://bit.ly/2HqTIoD
Further company coverage:  ADVIC.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 59 772 0920;))

Recent news on Advicenne SA

See all news